These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Activity of teicoplanin in localized experimental infections in rats. Arioli V; Berti M; Candiani G J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103 [TBL] [Abstract][Full Text] [Related]
6. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study. Pauluzzi S; Del Favero A; Menichetti F; Baratta E; Moretti VM; Di Filippo P; Pasticci MB; Guerciolini R; Patoia L; Frongillo RF J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643 [TBL] [Abstract][Full Text] [Related]
7. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA. LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644 [TBL] [Abstract][Full Text] [Related]
8. Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria. de Lalla F; Santoro D; Rinaldi E; Suter F; Cruciani M; Guaglianone MH; Rizzardini G; Pellegata G J Antimicrob Chemother; 1989 Jan; 23(1):131-42. PubMed ID: 2526109 [TBL] [Abstract][Full Text] [Related]
9. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections. Klastersky J; Van der Auwera P J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212 [TBL] [Abstract][Full Text] [Related]
10. Glycopeptides in the treatment of staphylococcal infections. Daschner FD; Kropec A Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466 [TBL] [Abstract][Full Text] [Related]
11. Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients. Testore GP; Uccella I; Sarrecchia C; Mattei A; Impagliazzo A; Sordillo P; Andreoni M J Chemother; 2000 Oct; 12(5):412-5. PubMed ID: 11128561 [TBL] [Abstract][Full Text] [Related]
13. Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? Mini E; Nobili S; Periti P Drugs; 1997; 54 Suppl 6():39-52. PubMed ID: 9474480 [TBL] [Abstract][Full Text] [Related]
15. Current problems of chemotherapy of infections with coagulase-negative staphylococci. Davies AJ; Stone JW Eur J Clin Microbiol; 1986 Jun; 5(3):277-81. PubMed ID: 3527698 [TBL] [Abstract][Full Text] [Related]
16. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy. Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703 [TBL] [Abstract][Full Text] [Related]
17. Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Frongillo RF; Donati L; Federico G; Martino P; Moroni M; Ortona L; Palumbo M; Pasticci BM; Pizzigallo E; Privitera G Antimicrob Agents Chemother; 1986 May; 29(5):789-96. PubMed ID: 3637066 [TBL] [Abstract][Full Text] [Related]
18. Coagulase-negative staphylococci emerging during teicoplanin therapy and the determination of their sensitivity. Jones RN J Antimicrob Chemother; 1992 Jun; 29(6):725-7. PubMed ID: 1387134 [No Abstract] [Full Text] [Related]
19. New antimicrobial agents for methicillin-resistant Staphylococcus aureus. Kollef MH Crit Care Resusc; 2009 Dec; 11(4):282-6. PubMed ID: 20001879 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic-associated diarrhoea and methicillin-resistant Staphylococcus aureus. McDonald M; Ward P; Harvey K Med J Aust; 1982 May; 1(11):462-4. PubMed ID: 7048039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]